SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-010768
Filing Date
2024-04-12
Accepted
2024-04-12 17:27:55
Documents
2
Period of Report
2024-04-10

Document Format Files

Seq Description Document Type Size
1 form3-04122024_090449.html 3  
1 form3-04122024_090449.xml 3 1752
2 ex24-04122024_090454.htm EX-24 8506
  Complete submission text file 0001415889-24-010768.txt   11832
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O BLACK DIAMOND THERAPEUTICS, INC. ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Campbell Shannon (Reporting) CIK: 0002018966 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39200 | Film No.: 24842522